IMMUNOSUPPRESSION

This study tested a new approach to help kidney transplant patients stop taking lifelong anti-rejection drugs. It involved 88 patients who received a kidney from a genetically matched sibling. The treatment combined a special medication (Campath-1H) with infusions of the donor's …

This study tested whether a specific type of COVID-19 booster vaccine (called a recombinant vaccine) could improve and sustain immune protection in people with weakened immune systems. It focused on adults with conditions like Inflammatory Bowel Disease (IBD) or those who have re…

This study tested the safety and effectiveness of an H1N1 flu vaccine in people who have received a kidney transplant. It involved 122 adult transplant recipients who were taking medications to suppress their immune systems. Researchers measured the body's immune response to the …

This study tested whether transplanting insulin-producing cells (islets) could help patients with type 1 diabetes who already had a kidney transplant. The goal was to help these patients become independent from insulin injections and better control their blood sugar. Researchers …

This study tested whether a mindfulness-based therapy program could help people who have received a liver transplant. The goal was to see if the therapy improved their motivation and, most importantly, their consistency in taking the anti-rejection medications they need to stay h…

This study aimed to see if measuring the level of a common virus (Torque Teno Virus) in the blood could help doctors better manage anti-rejection drugs for kidney transplant patients. Researchers followed 268 transplant recipients to see if the virus level correlated with drug le…